US Stock MarketDetailed Quotes
THRD Third Harmonic Bio
- 12.470
- +1.020+8.91%
Close Nov 22 16:00 ET
- 12.470
- 0.0000.00%
Post 16:02 ET
561.88MMarket Cap-21135P/E (TTM)
12.675High11.480Low148.08KVolume11.600Open11.450Pre Close1.83MTurnover1.15%Turnover RatioLossP/E (Static)45.06MShares16.94052wk High1.91P/B160.60MFloat Cap7.08052wk Low--Dividend TTM12.88MShs Float24.595Historical High--Div YieldTTM10.44%Amplitude3.750Historical Low12.377Avg Price1Lot Size
About Third Harmonic Bio Company
Third Harmonic Bio, Inc. develops pharmaceutical products for the treatment of allergic and immune diseases and disorders. It focuses on the development of the next wave of medicine for the treatment of allergic and inflammatory diseases. The company was founded on April 25, 2019 and is headquartered in San Francisco, CA.
Company Profile
SymbolTHRD
Company NameThird Harmonic Bio
Listing DateSep 15, 2022
Issue Price17.00
Founded2019
CEOMs. Natalie C. Holles
MarketNASDAQ
Employees30
Fiscal Year Ends12-31
Address1700 Montgomery Street,Suite 210
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94111
Phone1-209-727-2457
Websitehttp://thirdharmonicbio.com
Company Executives
- Name
- Position
- Salary
- Natalie C. Holles
- Chief Executive Officer and Director
- 2.54M
- Julie Person
- Chief Administrative Officer
- 1.11M
- Dr. Edward R. Conner, M.D.
- Chief Medical Officer
- 1.38M
- Christopher M. Murphy
- Chief Financial and Business Officer
- --
- Mark T. Iwicki
- Chairman of the Board
- 174.62K
- Dr. Geoff McDonough
- Director
- --
- Dr. H. Martin Seidel, PhD
- Independent Director
- 130.04K
- Dr. David P. Bonita, M.D.
- Independent Director
- 119.84K
- Thomas M. Soloway
- Independent Director
- 172.85K
- Robert J. Perez
- Independent Director
- 62.71K
- Dr. Geoffrey McDonough, M.D.
- Independent Director
- --
- Michael Gladstone
- Independent Director
- 119.84K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data